In attempt to assess treatment patterns in advanced gastric cancer across racial and ethnic groups throughout the U.S., ...

Results from the phase 3 EPCORE DLBCL-1 clinical trial show that patients with relapsed or refractory diffuse large B-cell ...

Oya Gilbert, diagnosed with myeloma in 2017, uses advocacy and music to improve awareness, access and support for patients ...

Patients share their experiences with myeloma relapses, discussing coping strategies, emotional challenges, and the ...

Patients share their personal journeys and insights on the decision-making process surrounding transplant options for cancer ...

Receiving a diagnosis of Chronic Myeloid Leukemia (CML) can be frightening, but it is important to understand that the management of this disease is one of the greatest success stories in modern ...

A diagnosis of uveal melanoma marks the beginning of a long-term relationship with your medical team. While the focus starts ...

Tecvayli and Darzalex combination shows unprecedented progression-free survival in relapsed/refractory multiple myeloma, ...

Large cell carcinoma is aggressive, requiring early detection through imaging and biopsy for optimal treatment outcomes.

The American Cancer Society’s 2026 Cancer Statistics report shows the five-year survival rate for all cancers has reached a ...

Providing patient-centered education and navigation support significantly increases consent rates for genomic testing, making ...

At Keck Medicine of USC, surgeons, oncologists and radiation specialists collaborate closely, ensuring individualized care ...